Testosterone enanthate is a synthetic form of testosterone attached to a chemical ester that slows its release into the body. It is one of the most widely prescribed medications for testosterone replacement therapy (TRT) in adult men with clinically low testosterone levels. Available as an injectable solution, it works by mimicking the body’s natural testosterone, restoring levels that the body can no longer produce on its own.
How It Works in the Body
The “enanthate” part of the name refers to a fatty acid chain attached to the testosterone molecule. This ester acts like a time-release mechanism. Once injected into muscle or subcutaneous tissue, enzymes in the body gradually clip off the ester, freeing active testosterone into the bloodstream over days rather than all at once. The terminal half-life of testosterone enanthate is roughly 4 to 5 days, meaning it takes that long for half the dose to be cleared.
After an injection, serum testosterone levels peak within 1 to 3 days and then gradually decline over the following weeks. By 2 to 3 weeks post-injection, levels can drop to as low as 25% of the peak value if the next dose isn’t given. This rise-and-fall pattern is why injections are typically repeated on a regular schedule.
Once free in the bloodstream, testosterone binds to androgen receptors throughout the body, the same receptors that natural testosterone uses. The body also converts some of it into two other hormones: dihydrotestosterone (a more potent androgen responsible for effects in skin, hair, and the prostate) and estradiol (a form of estrogen that plays a role in bone health and other functions). These conversions happen naturally and are part of normal testosterone metabolism.
What It Is Prescribed For
The FDA approves testosterone enanthate for testosterone replacement in adult men who have a confirmed deficiency or complete absence of the hormone. Diagnosis requires blood draws taken in the morning on at least two separate days, both showing testosterone levels below the normal range. There are two main categories of patients:
- Primary hypogonadism: The testes themselves don’t produce enough testosterone. Causes include undescended testes, surgical removal of a testicle, Klinefelter syndrome, chemotherapy, or toxic damage from alcohol or heavy metals.
- Hypogonadotropic hypogonadism: The brain’s signaling system that tells the testes to produce testosterone is impaired. This can result from pituitary tumors, head trauma, or radiation to the brain.
The FDA has not established the safety or efficacy of testosterone enanthate for age-related testosterone decline, sometimes called “low T.” It is also not approved for use in males under 18.
Typical Dosing and Schedule
The standard dosing range for intramuscular testosterone enanthate is 50 to 400 mg injected every 2 to 4 weeks, per FDA and Endocrine Society guidelines. In practice, many clinicians prescribe somewhere in the range of 100 to 200 mg and adjust based on follow-up blood work. Some protocols use more frequent, smaller injections (such as weekly or twice weekly) to smooth out the peaks and valleys in testosterone levels, though the labeled range remains every 2 to 4 weeks.
A subcutaneous formulation (brand name Xyosted) is also available, which uses a smaller needle and is injected into the fat layer beneath the skin rather than deep into muscle. Both routes deliver the same active compound.
Effects on Red Blood Cells
One of the most clinically significant effects of testosterone enanthate is its ability to stimulate red blood cell production. While a modest increase can be beneficial, too many red blood cells thickens the blood and raises the risk of clotting events. This condition, called erythrocytosis, is generally flagged when hematocrit (the percentage of blood volume occupied by red cells) rises above 52% in men.
Injectable formulations like enanthate carry the highest risk of this side effect compared to gels, patches, or implanted pellets. One comparison found that erythrocytosis (defined as hematocrit above 50%) occurred in about 66.7% of men using weekly injectable testosterone, versus 12.8% on transdermal gels. The reason is the sharp spike in testosterone levels that follows each injection. Supraphysiological levels are reached within days, and these peaks are a strong stimulus for red blood cell production. Regular blood monitoring is a standard part of TRT for this reason.
Effects on Cholesterol and Metabolism
Testosterone replacement in men with genuine deficiency tends to improve several metabolic markers. Studies associate TRT with reductions in LDL (“bad”) cholesterol, triglycerides, blood glucose, and blood pressure, along with increases in HDL (“good”) cholesterol. It can also decrease subcutaneous fat and increase muscle and bone mass. These benefits are most evident in men who were truly deficient before treatment, not in men with normal testosterone levels.
Who Should Not Use It
Testosterone enanthate is contraindicated in men with a history of prostate cancer or those suspected of having prostate cancer. Clinical guidelines also advise that men at high risk for developing prostate cancer should consider this a contraindication. Breast cancer in men is another listed contraindication.
Because testosterone can increase red blood cell counts, men with pre-existing polycythemia (already-elevated red blood cells) are generally not candidates. The medication can also worsen sleep apnea and is not used during pregnancy due to the risk of harm to a developing fetus.
Legal Status
Testosterone enanthate is classified as a Schedule III controlled substance under the U.S. Controlled Substances Act. This puts it in the same category as other anabolic steroids, meaning it requires a valid prescription, and unauthorized possession or distribution carries legal penalties. Pharmacies track and report dispensing, and prescriptions typically cannot be called in by phone in some states.
How It Compares to Testosterone Cypionate
Testosterone cypionate is the other widely used injectable ester in the U.S., and the two are nearly interchangeable in clinical practice. Both share the same FDA-recommended dosing range and frequency. The cypionate ester is slightly longer, giving it a marginally longer duration of action, but the difference is small enough that most clinicians treat them as equivalent. The choice between the two often comes down to availability, insurance coverage, or physician preference rather than any meaningful clinical difference.